Ro Khanna bought Rigel Pharmaceuticals Inc (NASDAQ: RIGL)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 1 trade in Rigel Pharmaceuticals Inc (RIGL) since 2021, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Ro Khanna bought $1,001 - $15,000 of Rigel Pharmaceuticals Inc (NASDAQ: RIGL) on September 7, 2021. Since that trade, RIGL is down -5.79% against the S&P 500 up +75.33%, an outperformance of -81.12%.
Data updated
Ro Khanna's RIGL trades vs the price
RIGL is down -5.79% since Ro Khanna bought on September 7, 2021, versus +75.33% for the S&P 500.
Performance since this trade
All Ro Khanna RIGL trades
Ro Khanna & RIGL trading FAQ
Is it legal for Ro Khanna to trade Rigel Pharmaceuticals Inc (RIGL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Rigel Pharmaceuticals Inc (RIGL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna buy RIGL?
Ro Khanna disclosed a purchase of $1,001 - $15,000 of Rigel Pharmaceuticals Inc (RIGL) on September 7, 2021, according to public STOCK Act filings.
How has RIGL performed since Ro Khanna's trade?
Since Ro Khanna bought RIGL on September 7, 2021, the stock is down -5.79%, versus +75.33% for the S&P 500 over the same period, an outperformance of -81.12%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional RIGL trades?
Quantellect tracks every disclosed congressional trade in Rigel Pharmaceuticals Inc (RIGL) on the Rigel Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's RIGL tradesAll congressional filings for Rigel Pharmaceuticals IncRo Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.